GENEVA, July 11 — Swiss regulators have approved the first-ever antimalarial drug specifically designed for newborns weighing less than 11 pounds, marking a breakthrough in efforts to treat the disease in the most vulnerable infants. Pharmaceutical giant Novartis developed the new formulation of artemether-lumefantrine, designed as a cherry-flavored, rapidly dissolving tablet that can be given […]